Juventas Therapeutics' Grant

Juventas Therapeutics raised a round of funding on , . Investors include The Global Cardiovascular Innovation Center.

Juventas Therapeutics, formerly AcelleRx Therapeutics, Juventas Therapeutics is a privately held, clinical stage biotechnology company focused on developing non-viral gene therapies to treat advanced …

Articles about Juventas Therapeutics' Grant: